| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/28/2011 | US20110098190 Sirt4 activities |
| 04/28/2011 | US20110098188 Blood biomarkers for psychosis |
| 04/28/2011 | US20110098185 Composition and method for determining of esophageal cancer |
| 04/28/2011 | US20110098183 Plants with increased yield and/or increased tolerance to environmental stress (iy-bm) |
| 04/28/2011 | US20110097820 Swab-Based Diagnostic Systems |
| 04/28/2011 | US20110097819 Membrane-coated particles |
| 04/28/2011 | US20110097817 Reaction device for analyzing biological samples and relative method |
| 04/28/2011 | US20110097811 Oxygen detector and method for manufacturing oxygen detector |
| 04/28/2011 | US20110097810 Control of n-(phosphonomethyl)iminodiacetic acid conversion in manufacture of glyphosate |
| 04/28/2011 | US20110097809 Flue Gas Monitoring And Dynamic Spiking For Sulfur Trioxide/Sulfuric Acid |
| 04/28/2011 | US20110097808 Sensor-Dispensing Instruments |
| 04/28/2011 | US20110097807 Method and system to provide personalized pharmaceutical compositions and dosages |
| 04/28/2011 | US20110097806 Method of assessing cancer status in a breast cancer patient |
| 04/28/2011 | US20110097805 Kokumi-imparting agent |
| 04/28/2011 | US20110097788 Nano and micro-technology virus detection method and device |
| 04/28/2011 | US20110097752 COPD Diagnosis |
| 04/28/2011 | US20110097751 Glp-1 receptor agonist bioassays |
| 04/28/2011 | US20110097750 Method of quantitative assessment on reproductive effort of black-lip pearl oysters using antibody specific thereto |
| 04/28/2011 | US20110097749 Process for producing hepcidin |
| 04/28/2011 | US20110097748 Use of cell lines to determine levels of efficacy of pharmaceutical formulations |
| 04/28/2011 | US20110097747 Monoclonal antibody binds antigen associated with human tumors |
| 04/28/2011 | US20110097746 Orthogonal Method for the Removal of Transmissible Spongiform Encephalopathy Agents from Biological Fluids |
| 04/28/2011 | US20110097745 Method For Detecting Microbes |
| 04/28/2011 | US20110097744 Cellular COPD Diagnosis |
| 04/28/2011 | US20110097743 Compositions and methods of detecting tiabs |
| 04/28/2011 | US20110097742 Contrast agents, methods for preparing contrast agents, and methods of imaging |
| 04/28/2011 | US20110097741 Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays |
| 04/28/2011 | US20110097740 Real-time continuous detection device |
| 04/28/2011 | US20110097739 Blood-brain barrier epitopes and uses thereof |
| 04/28/2011 | US20110097738 Plasma biomarker tool for the diagnosis of liver cancer comprising liver carboxylesterase 1 and liver cancer screening method |
| 04/28/2011 | US20110097737 Methods and Compositions for Targeting Proteins of Interest to the Host Cell Envelope |
| 04/28/2011 | US20110097736 Methods of determining levels of free amino acid and dipeptides and diagnosing alzheimer's diseases |
| 04/28/2011 | US20110097735 Fluorescent pyrene compounds |
| 04/28/2011 | US20110097734 Flow Control Technique for Assay Devices |
| 04/28/2011 | US20110097733 Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite |
| 04/28/2011 | US20110097732 Novel biomarker for the prognosis of breast cancer |
| 04/28/2011 | US20110097726 Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 04/28/2011 | US20110097723 Methods and reagents for analyte detection |
| 04/28/2011 | US20110097718 Ms-compatible nonionic or zwitterionic surfactants in free-flow electrophoresis |
| 04/28/2011 | US20110097715 Method for purifying or detecting a target protein |
| 04/28/2011 | US20110097710 Methods for detecting atrial fibrillation and related conditions |
| 04/28/2011 | US20110097708 Assessment of human papilloma virus-related disease |
| 04/28/2011 | US20110097706 Micro-reactor for observing particles in a fluid |
| 04/28/2011 | US20110097705 Surface-assisted hemagglutination and hemagglutination inhibition assays |
| 04/28/2011 | US20110097423 Gene Prognosis Predictor Signature for Colorectal Carcinoma |
| 04/28/2011 | US20110097390 Ultra-Small RNAs as Toll-Like Receptor-3 Antagonists |
| 04/28/2011 | US20110097389 P53 biomarkers |
| 04/28/2011 | US20110097353 Poultry viral materials and methods related thereto |
| 04/28/2011 | US20110097343 Diagnosis and therapy of hematological malignancies |
| 04/28/2011 | US20110097334 Novel Marker Genes for Regulatory T Cells from Human Blood |
| 04/28/2011 | US20110097333 Therapeutic and diagnostic agents |
| 04/28/2011 | US20110097331 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 04/28/2011 | US20110097327 Product and method for treatment of conditions associated with receptor-desensitization |
| 04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
| 04/28/2011 | US20110097319 Antibody Capable of Binding Specifically to AB-Oligomer, and Use Thereof |
| 04/28/2011 | US20110097317 Thioredoxin Interacting Protein (TXNIP) As Regulator Of Vascular Function |
| 04/28/2011 | US20110097300 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 04/28/2011 | US20110097262 NOVEL ANTI-cMET ANTIBODY |
| 04/28/2011 | US20110097261 Amigo-2-inhibitors for treating, diagnosing or detecting cancer |
| 04/28/2011 | US20110095190 Elemental composition detection system and method |
| 04/28/2011 | US20110094882 Test meter for use with a dual chamber, multi-analyte test strip with opposing electrodes |
| 04/28/2011 | US20110094591 Microfluidic device initialization method, microfluidic device initialization apparatus and microfluidic device package |
| 04/28/2011 | US20110094321 Preparation of aprepitant |
| 04/28/2011 | US20110094289 Apparatus and Method of Washed Hand and Object Detection |
| 04/28/2011 | DE202010013088U1 Umweltsensor Environmental sensor |
| 04/28/2011 | DE202004021824U1 Mikroprozessoren und Vorrichtungen zur Überwachung von physiologischen Analyten Microprocessors and devices for monitoring physiological analytes |
| 04/28/2011 | DE112009001234T5 Mittel und Verfahren zur Abschätzung von Lebertoxizität Means and methods for assessment of liver toxicity |
| 04/28/2011 | DE102009051686A1 Verfahren zur Bestimmung der Weichheit von Tissuepapier A method for determining the softness of tissue paper |
| 04/28/2011 | DE102009050175A1 Biochip, zugehöriges Untersuchungsgerät und entsprechendes Betriebsverfahren Biochip associated examination apparatus and corresponding operating method |
| 04/28/2011 | DE102009050075A1 Verfahren zur Messung der Wolkigkeit von Lackierungen auf Prüftafeln Method for measuring the cloudiness of paint to test panels |
| 04/28/2011 | DE102009045940A1 Method for monitoring aroma of e.g. coffee in insulated container in office, involves monitoring measurement values based on limit values, and signalizing conditions of beverages when obtaining exclusion areas in three-dimensional map |
| 04/28/2011 | DE102008053503B4 Immunologischer Test zum Nachweis von Autoantikörpern gegen testikuläre Antigene An immunological assay for the detection of autoantibodies against testicular antigens |
| 04/28/2011 | CA2779309A1 Method for treating androgen receptor positive cancers |
| 04/28/2011 | CA2778613A1 Methods and compositions for panic disorders |
| 04/28/2011 | CA2778533A1 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 04/28/2011 | CA2778497A1 Cell free cd4 quantitation and methods of use |
| 04/28/2011 | CA2778478A1 Detection and treatment of lrp4-associated neurotransmission disorders |
| 04/28/2011 | CA2778446A1 Self cleaning optical probe |
| 04/28/2011 | CA2778442A1 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein |
| 04/28/2011 | CA2778401A1 Integrin alpha 8-beta 1-specific monoclonal antibody |
| 04/28/2011 | CA2778328A1 Method of using non-rare cells to detect rare cells |
| 04/28/2011 | CA2778284A1 Incoherent lensfree cell holography and microscopy on a chip |
| 04/28/2011 | CA2778059A1 Methods for diagnosis of immune responses against viruses |
| 04/28/2011 | CA2777934A1 Proximity-mediated assays for detecting oncogenic fusion proteins |
| 04/28/2011 | CA2777883A1 Medical utility of glycan-binding proteins and glycans |
| 04/28/2011 | CA2777794A1 Nested cell encapsulation |
| 04/28/2011 | CA2777480A1 Antibodies, systems and methods for determining relative hemolytic index |
| 04/28/2011 | CA2777420A1 Tivozanib response prediction |
| 04/28/2011 | CA2777411A1 Immunochemical detection of single target entities |
| 04/28/2011 | CA2776978A1 Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof |
| 04/28/2011 | CA2776576A1 Non-cross-reactive anti-igg antibodies |
| 04/28/2011 | CA2776405A1 Surface-assisted hemagglutination and hemagglutination inhibition assays |
| 04/28/2011 | CA2775924A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2011 | CA2774871A1 Screening method utilizing thalidomide-targeting factor |
| 04/28/2011 | CA2773478A1 System for determining unprocessed and partially processed neurotoxin type a |
| 04/27/2011 | EP2315145A1 Methods, systems, and software for identifying functional biomolecules |
| 04/27/2011 | EP2315035A2 Sample processing unit and sample processing method |
| 04/27/2011 | EP2315034A2 Means and methods for assessing the risk of cardiac interventions based on GDF-15 |
| 04/27/2011 | EP2315033A2 Compositions and methods for treating skin disorders |
| 04/27/2011 | EP2315032A1 3-Nitrotyrosinated fibrinogen as a diagnostic marker in ischemic stroke and uses thereof |